Press Release: Leveraging Digital Twins for Pharma Transformation
At the forefront of digital transformation in the pharmaceutical industry, Shoeb Javed, Chief Product Officer at iGrafx, emphasized the potential of Digital Twins of Organizations (DTO) at the Technology Networks’ Laboratory of the Future 2025 event. A DTO serves as a dynamic virtual version of a company’s operations, offering real-time insights into business processes from drug discovery to manufacturing.
“In essence, DTOs are not just static maps; they evolve alongside the organization,” Javed explained, showcasing how the technology harnesses data from various enterprise systems to highlight inefficiencies and risks. DTOs employ advanced techniques like process mining, task mining, and predictive analytics to continually optimize workflows.
AI plays a crucial role in enhancing these systems, transforming them into intelligent decision-making tools. Machine learning algorithms help predict workflow outcomes, identify compliance risks, and offer corrective actions to mitigate potential issues. For instance, if a regulatory step in a workflow is overlooked, the DTO can proactively alert users to avert future problems, thereby saving crucial resources.
Illustrating the value of DTOs, Javed cited a case study from a global pharmaceutical company facing multiple simultaneous challenges, including supply chain issues and a critical drug launch window. By implementing iGrafx’s AI-enhanced solution, the company improved 40 workflows and avoided significant financial losses.
For organizations looking to implement DTOs, Javed recommends starting with a centralized process repository to lay the foundation for effective process mining. He advocates that digital twins are more than tools; they are transformative frameworks poised to turn industry challenges into opportunities, with AI steering continuous adaptation and improvement.
For further insights on integrating DTOs within your operations, please reach out to iGrafx.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
